<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Allergic and asthmatic reactions to food additives</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Allergic and asthmatic reactions to food additives</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Allergic and asthmatic reactions to food additives</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ronald A Simon, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott H Sicherer, MD, FAAAAI</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 14, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The list of additives used in the food industry is extensive and includes thousands of natural and synthetic substances used as flavorings, coloring substances, preservatives, sweeteners, antioxidants, thickeners, etc. However, only a small number of additives have been implicated in immunoglobulin E (IgE)-mediated or other (immunologic or nonimmunologic) adverse reactions.</p><p>Food additives that have been linked to urticaria/angioedema, asthma, and anaphylaxis will be discussed here. Food additives that cause asthma/rhinitis in food industry workers and testing and challenge procedures for food additives are mentioned briefly here and reviewed in more detail separately. (See  <a class="medical medical_review" href="/d/html/538.html" rel="external">"Occupational asthma: Pathogenesis"</a> and  <a class="medical medical_review" href="/d/html/7529.html" rel="external">"Occupational rhinitis"</a> and  <a class="medical medical_review" href="/d/html/16707.html" rel="external">"Testing and challenge procedures to evaluate allergic and asthmatic reactions to food additives"</a>.)</p><p>Issues surrounding food additives that are <strong>not</strong> discussed in this topic review include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Hyperactivity and behavioral changes in children (see  <a class="medical medical_review" href="/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Oncogenic potential of food additives (see  <a class="medical medical_review" href="/d/html/2617.html" rel="external">"Risk factors for gastric cancer"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dietary factors and headache (see  <a class="medical medical_review" href="/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults"</a>)</p><p></p><p class="headingAnchor" id="H10180362"><span class="h1">OVERVIEW</span><span class="headingEndMark"> — </span>Food additives may be classified by function. Additives that affect the chemical or structural characteristics of foods include emulsifiers, acidulants, buffers, raising agents, and enzymes. Shelf-life extenders include preservatives, antioxidants, and curing/pickling agents. Thickeners, colors, gelling agents, and non-nutritive sweeteners are added to alter the sensory characteristics of foods. Food additives are identified in the United States by their English names or, in the European Union, by a unique identifying number, the "E number" [<a href="#rid1">1,2</a>].</p><p class="headingAnchor" id="H1213672"><span class="h2">Epidemiology</span><span class="headingEndMark"> — </span>Patients and parents of young children suspect allergy and intolerance to food additives far more often than it can be verified [<a href="#rid3">3</a>]. The prevalence of a reaction to food additives was only 0.23 percent in a population-based study [<a href="#rid3">3,4</a>]. Many of the cases of adverse reactions attributed to food additives that are reported in the medical literature are either anecdotal or characterized by poorly-controlled challenge procedures. In reality, relatively few food additives have been convincingly demonstrated to cause reactions, such as urticaria, angioedema, asthmatic reactions, or anaphylaxis [<a href="#rid5">5-10</a>].</p><p>Allergic reactions to nutritive foods (eg, tree nuts or seafood) are far more prevalent than reactions to food additives, and food allergy must always be considered first in the differential diagnosis. (See  <a class="medical medical_review" href="/d/html/2398.html" rel="external">"Clinical manifestations of food allergy: An overview"</a>.)</p><p class="headingAnchor" id="H10180518"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>Food additives should be considered as a possible cause of allergic or asthmatic reactions when signs/symptoms occur in association with meals or other ingestions (candy, etc).</p><p>Clues that the patient may be reacting to a food additive include [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Allergic or asthmatic reactions that occur in timely association with meals or other ingestions (ie, usually within minutes to a few hours of eating).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A convincing history of symptoms to several apparently unrelated foods.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reactions to commercially prepared forms of foods that are tolerated when prepared at home.</p><p></p><p>The following types of allergic and asthmatic reactions to food additives have been reported:</p><p class="bulletIndent1"><span class="glyph">●</span>Anaphylaxis – Classic immunoglobulin E (IgE)-mediated allergic reactions most commonly involve one or more of the following signs and symptoms: flushing, urticaria, pruritus, angioedema, bronchospasm, nausea, vomiting, or throat tightness  (<a class="graphic graphic_table graphicRef79448" href="/d/graphic/79448.html" rel="external">table 1</a>). Anaphylaxis is the most severe form of an IgE-mediated allergy. Diagnostic criteria for anaphylaxis are shown in the figure  (<a class="graphic graphic_figure graphicRef82831" href="/d/graphic/82831.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Isolated asthmatic reactions in people known to have asthma.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urticaria and angioedema, alone or in combination.</p><p></p><p>In contrast, there are no known associations between food additives and other chronic atopic conditions, such as atopic dermatitis or eosinophilic esophagitis [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H1752738"><span class="h3">Reactions to multiple additives</span><span class="headingEndMark"> — </span>When patients do have a true adverse or allergic reaction to a food additive, it is generally caused by a single agent. The medical literature does not support the notion of patients being broadly "chemically-sensitive." The evaluation of patients with apparent "multiple chemical sensitivity" is discussed separately. (See  <a class="medical medical_review" href="/d/html/7764.html" rel="external">"Idiopathic environmental intolerance (multiple chemical sensitivity)"</a>.)</p><p class="headingAnchor" id="H1213920"><span class="h3">Other types of reactions</span><span class="headingEndMark"> — </span>There are many nonallergic reactions that also need to be considered in the patient presenting with reactions related to food ingestion  (<a class="graphic graphic_table graphicRef51225" href="/d/graphic/51225.html" rel="external">table 2</a>). These are mentioned separately. (See  <a class="medical medical_review" href="/d/html/2398.html" rel="external">"Clinical manifestations of food allergy: An overview", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">URTICARIA/ANGIOEDEMA</span></p><p class="headingAnchor" id="H10181207"><span class="h2">Patients with chronic urticaria</span><span class="headingEndMark"> — </span>Chronic urticaria (CU) is defined as the presence of urticaria (hives) most days of the week for a period of six weeks or longer. CU is inherently variable, and when the disorder first develops, many patients will try to make an association with specific foods or food additives. However, clinically relevant allergies to foods or food additives are rare in patients with CU. Clinicians should not routinely advise patients with CU to avoid food additives [<a href="#rid5">5</a>].</p><p>Although allergies rarely cause this disorder, a subset of patients with CU will notice that symptoms are exacerbated (not caused) by foods that have high levels of natural histamine-like chemicals. The relationship between diet and symptom severity in CU is reviewed in more detail separately. </p><p>The most accurate means to assess a possible adverse reaction is to utilize double-blind, placebo-controlled challenge protocols, as is done with food challenges [<a href="#rid12">12,13</a>]. However, challenges are particularly difficult to perform in patients with CU, because, on one hand, withdrawal of antihistamines can result in increased symptoms that can be misinterpreted as a positive challenge. On the other hand, the patient is unlikely to react to challenge if full doses of antihistamine are continued, yielding false-negative results.</p><p>In a study of 100 patients with CU evaluated at the author's center over a 10-year period, subjects were challenged with 11 common food and drug additives. Forty-three percent of the group reported suspected reactions to additives. Prior to challenge, antihistamines were tapered to the "minimal effective dose" that allowed patients to be comfortable, but not hive-free. Subjects were then given a single-blind challenge consisting of multiple opaque capsules containing the following additives [<a href="#rid14">14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Monosodium glutamate (MSG)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="120131" href="/d/drug information/120131.html" rel="external">Sodium benzoate</a></p><p class="bulletIndent1"><span class="glyph">●</span>Methyl paraben</p><p class="bulletIndent1"><span class="glyph">●</span>Butylated hydroxyanisole (BHA)</p><p class="bulletIndent1"><span class="glyph">●</span>Butylated hydroxytoluene (BHT)</p><p class="bulletIndent1"><span class="glyph">●</span>Tartrazine (FD&amp;C Yellow #5, E102)</p><p class="bulletIndent1"><span class="glyph">●</span>Sunset yellow (FD&amp;C Yellow #6, E110)</p><p class="bulletIndent1"><span class="glyph">●</span>Sodium nitrate</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="85782" href="/d/drug information/85782.html" rel="external">Sodium nitrite</a></p><p class="bulletIndent1"><span class="glyph">●</span>Aspartame</p><p class="bulletIndent1"><span class="glyph">●</span>Potassium metabisulfite</p><p></p><p>Criteria for a positive challenge used "skin scores" of urticarial lesions. Skin scores for several hours after the challenge were compared with scores from the previous three days. Two patients had an increase of 30 percent in their skin scores following the initial challenge [<a href="#rid14">14</a>]. After two weeks, these two patients underwent double-blind, placebo-controlled challenges with each additive separately on 11 different days. Neither patient reacted to any additives. Thus, none of the 100 patients was sensitive to any of the additives tested, suggesting that reactivity to food additives in patients with CU is rare, if it occurs at all. The multiple-additive challenge protocol used in this study is reviewed separately. (See  <a class="medical medical_review" href="/d/html/16707.html" rel="external">"Testing and challenge procedures to evaluate allergic and asthmatic reactions to food additives", section on 'Mixed additive challenge'</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Additives implicated in case reports</span><span class="headingEndMark"> — </span>BHA, BHT, aspartame, and lysozyme have been implicated in causing urticaria or angioedema in isolated case reports.</p><p class="headingAnchor" id="H4"><span class="h3">BHA and BHT</span><span class="headingEndMark"> — </span>Butylated hydroxyanisole (BHA) (E320) and butylated hydroxytoluene (BHT) (E321) are antioxidants commonly used in breakfast cereals and other grain products to maintain crispness and prevent rancidity. There is one well-documented report of CU, confirmed by double-blind, placebo-controlled challenges, exacerbated by these agents [<a href="#rid15">15</a>]. Sensitive subjects exhibited improvement in urticaria after elimination of BHA and BHT from the diet.</p><p class="headingAnchor" id="H5"><span class="h3">Aspartame</span><span class="headingEndMark"> — </span>Aspartame (NutraSweet), a dipeptide, is a low-calorie artificial sweetener [<a href="#rid16">16</a>]. Two cases of aspartame-induced urticaria, confirmed by placebo-controlled, double-blind challenge, have been reported [<a href="#rid17">17</a>], and additional cases by the same author have also been described [<a href="#rid18">18</a>]. However, other investigators have encountered difficulty recruiting subjects with adverse reactions to aspartame and have found that such subjects do not have reproducible reactions [<a href="#rid19">19,20</a>].</p><p class="headingAnchor" id="H6"><span class="h3">Lysozyme</span><span class="headingEndMark"> — </span>Lysozyme in egg, aged cheeses, and pharmaceuticals was implicated in a case report of recurrent angioedema [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H8"><span class="h1">ASTHMATIC SYMPTOMS</span><span class="headingEndMark"> — </span>Sulfites are the only compounds that have been convincingly demonstrated to provoke asthmatic reactions in a small subset of asthmatic patients [<a href="#rid5">5</a>]. Affected patients typically have severe, steroid-dependent asthma [<a href="#rid22">22,23</a>]. The evidence that other additives can provoke asthma, especially benzoate, monosodium glutamate (MSG), and tartrazine, is limited to case reports and has not been supported by rigorous double-blind, placebo-controlled challenges.</p><p class="headingAnchor" id="H9"><span class="h2">Sulfites and related compounds</span><span class="headingEndMark"> — </span>Sulfites have been widely used for centuries to freshen and prevent oxidative discoloration (browning) of foods. Sulfites are also used as sanitizers and to inhibit the growth of undesirable micro-organisms in the fermentation industry. Sulfiting agents include sulfur dioxide, sodium potassium sulfite, bisulfite, and metabisulfite. Foods containing sulfites are listed in the table  (<a class="graphic graphic_table graphicRef66943" href="/d/graphic/66943.html" rel="external">table 3</a>). The highest levels of sulfites are found in commercially prepared dried fruits (such as apricots), potatoes, wines, and some seafood items [<a href="#rid24">24</a>].</p><p>Sulfiting agents can cause serious and potentially life-threatening asthmatic reactions in patients with asthma, as demonstrated in double-blind controlled studies [<a href="#rid22">22,23,25</a>]. As many as 5 percent of the asthmatic population may experience adverse reactions from mild wheezing to severe bronchospasm following ingestion of sulfite-containing foods or beverages [<a href="#rid23">23,26,27</a>]. Asthmatic reactions in patients without underlying asthma appear to be uncommon.</p><p>While any asthmatic may develop sulfite sensitivity, many sulfite-sensitive asthmatics have more severe asthma and are steroid-dependent. Therefore, one should consider sulfite sensitivity in moderate/severe or steroid-dependent asthmatics who give a history of reacting to foods/beverages likely to contain moderate-to-high levels of sulfites  (<a class="graphic graphic_table graphicRef66943" href="/d/graphic/66943.html" rel="external">table 3</a>).</p><p class="headingAnchor" id="H10"><span class="h2">Tartrazine (FD&amp;C Yellow 5)</span><span class="headingEndMark"> — </span>Tartrazine (FD&amp;C Yellow #5 or E102) is an acidic dye derived from <a class="drug drug_general" data-topicid="8878" href="/d/drug information/8878.html" rel="external">coal tar</a> that is used as a colorant in foods and medications. It was reported to provoke bronchospasm in patients with asthma, although the studies that supported this conclusion in the 1960s and 1970s lacked adequate controls by modern standards [<a href="#rid28">28-31</a>]. It was also believed by some clinicians at the time that tartrazine "cross-reacts" with nonsteroidal anti-inflammatory drugs (NSAIDs) and should be avoided by patients with aspirin-exacerbated respiratory disease (AERD). However, tartrazine is not a cyclooxygenase-1 (COX-1) inhibitor like NSAIDs, and subsequent studies have shown it is well-tolerated in patients with AERD. Well-controlled studies have also suggested that tartrazine sensitivity in other asthmatic patients is rare.</p><p class="bulletIndent1"><span class="glyph">●</span>Two double-blind, placebo-controlled studies each found no tartrazine-sensitive subjects among approximately 50 adult and pediatric subjects with chronic, frequently steroid-dependent asthma [<a href="#rid32">32,33</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Double-blind, placebo-controlled challenge protocols in aspirin-sensitive asthmatics found no adverse reactions in 165 patients challenged to a dose of 50 mg of tartrazine [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2001 systematic review identified six randomized trials examining the effects of tartrazine in patients with asthma, both with and without <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> sensitivity. Only three included analyzable data, and these were not comparable, so no formal conclusions were drawn [<a href="#rid35">35</a>]. However, tartrazine challenges or tartrazine avoidance were not found to affect asthma symptoms in any of the six trials.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 26 atopic patients with either asthma, allergic rhinitis, urticaria, or pseudoallergic reactions to NSAIDs, subjects underwent double-blind, placebo-controlled challenge with 25 mg of tartrazine and demonstrated no increase in symptoms [<a href="#rid36">36</a>].</p><p></p><p>Therefore, based on the available evidence, avoidance of tartrazine in patients with asthma is not justified.</p><p class="headingAnchor" id="H11"><span class="h2">Sodium benzoate</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="120131" href="/d/drug information/120131.html" rel="external">Sodium benzoate</a> (E211) is used as an antimicrobial preservative in foods. There has been only one subject in the medical literature shown to have benzoate-provoked asthma, as reported in a double-blind, placebo-controlled study [<a href="#rid37">37</a>]. This patient was not aspirin-sensitive and did not experience amelioration of asthma symptoms while on a benzoate-free diet.</p><p class="headingAnchor" id="H12"><span class="h2">Spearmint, peppermint, and menthol</span><span class="headingEndMark"> — </span>The flavorings spearmint (<em>Mentha spicata</em>), peppermint (<em>Mentha piperita</em>), and menthol (<em>Mentha labiatae</em>) used in chewing gum and toothpaste have been confirmed by challenges in two cases to have triggered asthma [<a href="#rid38">38,39</a>]. Anaphylaxis was described in another case report [<a href="#rid40">40</a>].</p><p class="headingAnchor" id="H14"><span class="h1">ANAPHYLAXIS</span><span class="headingEndMark"> — </span>Several natural food additives have been implicated in causing anaphylaxis, and reports have become more common as consumer preference for products containing only "natural" ingredients has increased. Over the past decades, food manufacturers have been replacing synthetic food additives with compounds derived from plant, insect, and animal products. Because most immunoglobulin E (IgE)-mediated allergy is caused by proteins from other living organisms, this switch to natural agents has been associated with an increase in IgE-mediated allergies to these substances. As examples, case reports have described the potential for anaphylaxis with annatto, carmine, <a class="drug drug_general" data-topicid="9834" href="/d/drug information/9834.html" rel="external">psyllium</a>, and guar gum [<a href="#rid41">41-44</a>]. IgE-mediated allergy to spices also occurs.</p><p class="headingAnchor" id="H16"><span class="h2">Annatto</span><span class="headingEndMark"> — </span>Annatto (E160b) is a yellow food coloring used to color a variety of foods, including cereal, cheese, ice cream, margarine, oils, and beverages. Annatto dye extract is produced from the pericarp of the fruit of the annatto tree, <em>Bixa orellana</em>. Anaphylaxis to annatto has been reported [<a href="#rid43">43,45</a>].</p><p class="headingAnchor" id="H17"><span class="h2">Carmine</span><span class="headingEndMark"> — </span>Carmine (E120), or cochineal extract, is a red food dye derived from the dried bodies of female <em>Dactylopius coccus</em> Costa insects [<a href="#rid46">46</a>]. Carmine is used in foodstuffs, such as candy, ice cream, yogurt, cookies, pastries, syrups, liqueurs, vinegar, cheese, butter, delicatessen meats, jam, and caviar, as well as in cosmetics. It has been implicated in anaphylaxis as well as occupational asthma [<a href="#rid44">44,47</a>]. (See  <a class="medical medical_review" href="/d/html/538.html" rel="external">"Occupational asthma: Pathogenesis"</a>.)</p><p>Allergic symptoms following carmine ingestion appear rapidly in some individuals but are delayed by several hours in others, for reasons which are not clear [<a href="#rid46">46</a>]. Skin testing is informative, although positive results may appear after 30 minutes, rather than the usual 15 minutes [<a href="#rid48">48</a>].</p><p class="headingAnchor" id="H19"><span class="h2">Erythritol</span><span class="headingEndMark"> — </span>Erythritol (ERT; 1,2,3,4-butanetetrol) is a 4-carbon sugar alcohol prepared from glucose by fermentation that is used as a sweetener [<a href="#rid42">42</a>]. It may also occur naturally in foods, such as wine, beer, soy, cheese, mushroom, grape, and watermelon. Anaphylaxis has been reported after ingestion of ERT-containing foods [<a href="#rid42">42</a>].</p><p class="headingAnchor" id="H20"><span class="h2">Guar gum</span><span class="headingEndMark"> — </span>Guar gum (E412) is a galactomannan derived from the guar bean, which is used as an emulsifier and binder in foods and pharmaceuticals. Guar gum has been implicated in severe anaphylaxis, as well as occupational rhinitis/asthma [<a href="#rid49">49-52</a>].</p><p class="headingAnchor" id="H21"><span class="h2">Psyllium</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9834" href="/d/drug information/9834.html" rel="external">Psyllium</a> is a source of soluble dietary fiber derived from the husks of <em>Plantago ovata</em> seeds. Psyllium is commonly used in bulk laxatives and fiber-enriched breakfast cereals. Allergic reactions, including severe anaphylaxis, have been reported [<a href="#rid53">53</a>]. Psyllium can also be a source of occupational asthma/rhinitis [<a href="#rid54">54-56</a>]. Health care workers who have prepared and handled psyllium-containing bulk laxatives appear to be at particular risk [<a href="#rid53">53</a>].</p><p class="headingAnchor" id="H1910516363"><span class="h2">Sulfites</span><span class="headingEndMark"> — </span>A small number of cases of anaphylaxis related to sulfite ingestion with positive skin tests have been reported [<a href="#rid41">41,57</a>]. One patient had monoclonal mast cell activation syndrome [<a href="#rid58">58</a>]. In addition, three reports assessed sulfite sensitivity in subjects with idiopathic anaphylaxis. In one report, 1 subject among 130 challenged was found to be sulfite-sensitive [<a href="#rid59">59</a>]. In another report, one subject experienced a systemic reaction following a sulfite skin test [<a href="#rid60">60</a>]. A third report found no sulfite sensitivity [<a href="#rid61">61</a>].</p><p><a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">Epinephrine</a> autoinjectors contain small amounts of sulfite, although this is not a contraindication to their use. This is discussed below. (See <a class="local">'Patients with anaphylaxis'</a> below.)</p><p class="headingAnchor" id="H22"><span class="h2">Other additives</span><span class="headingEndMark"> — </span>Several other additives have been implicated in anaphylaxis, including the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Carrageenan is a gelatinous polysaccharide derived from seaweed, which is used as a stabilizer and thickener. It has been implicated in anaphylaxis caused by a <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> enema solution [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lupine flour is an inexpensive flour extender that has been implicated in allergic reactions [<a href="#rid63">63,64</a>]. Lupine may have some cross-reactivity with peanut. (See  <a class="medical medical_review" href="/d/html/2413.html" rel="external">"Food allergens: Clinical aspects of cross-reactivity", section on 'Peanut'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pectin, a jelling agent and thickener, has been reported to cause anaphylaxis upon ingestion and occupational asthma upon inhalation [<a href="#rid65">65</a>]. Pectin may cross-react with cashew [<a href="#rid65">65</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gelatin in gummy candies and fruit chews has caused anaphylaxis [<a href="#rid66">66,67</a>]. Gelatin in vaccines (particularly in Japan) has been more frequently implicated in anaphylaxis. (See  <a class="medical medical_review" href="/d/html/2074.html" rel="external">"Allergic reactions to vaccines"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mycoprotein is fermented fungus (<em>Fusarium venenatum</em>) bound with egg albumin. It shares common allergenic determinants with other molds. Mycoprotein is used as a meat substitute (marketed as Quorn in the United States). Allergic reactions, including anaphylaxis, have been reported, mainly in patients with inhalant mold allergy [<a href="#rid68">68-70</a>].</p><p></p><p class="headingAnchor" id="H1001422"><span class="h2">Spices</span><span class="headingEndMark"> — </span>The term "spice" is often used to describe a variety of flavoring agents. Items that can be considered spices include allspice (a type of pepper), basil, cardamom, celery, chives, cinnamon, coriander, cumin, dill, fennel, garlic, ginger, marjoram, nutmeg, onion, oregano, parsley, pepper, peppermint, rosemary, saffron, sage, savory, star anise, tarragon, tumeric, and vanilla. Seeds (eg, poppy, sesame, caraway, mustard) are sometimes considered spices within the food industry.</p><p>Many types of pepper are used for spice (eg, bell, red, cayenne). In addition, many spices that are "hot" or "spicy" contain a chemical, <a class="drug drug_general" data-topicid="8840" href="/d/drug information/8840.html" rel="external">capsaicin</a>, which triggers burning sensations in normal individuals that could be misinterpreted as an allergic reaction, especially in a child.</p><p>Allergic reactions and anaphylaxis to a variety of spices have been reported and usually affect adults. In a French study, allergy to spices was estimated to account for approximately 2 percent of adults with food-allergic reactions and was rare in children [<a href="#rid71">71</a>]. The most allergenic groups of spices were those of the Apiaceae family (coriander, caraway, fennel, celery, chervil, and dill) and Liliaceae family (garlic, onion, chive, shallot, and saffron). Most individuals allergic to spices have concomitant allergy to inhaled pollens (especially birch and mugwort) and experience allergic reactions upon ingesting spices that contain proteins with homology to pollen proteins. Spice allergy is discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/2403.html" rel="external">"Pathogenesis of oral allergy syndrome (pollen-food allergy syndrome)"</a>.)</p><p class="headingAnchor" id="H7548074"><span class="h1">REACTIONS TO MSG</span><span class="headingEndMark"> — </span>Monosodium glutamate (MSG) is a nonessential dicarboxylic amino acid that is a normal constituent of food protein. Additional MSG is added to food as a flavor enhancer, particularly in Asian food. A variety of nonallergic symptoms have been attributed to MSG, while allergic and asthmatic reactions are only rarely reported and generally not well-substantiated.</p><p class="headingAnchor" id="H10181006"><span class="h2">MSG symptom complex</span><span class="headingEndMark"> — </span>Perhaps the best known adverse reaction to a food additive is the MSG symptom complex. This is not an allergic reaction.</p><p>The MSG symptom complex typically appears 1 to 14 hours after ingestion. Reported symptoms include headache, myalgia, backache, neck pain, nausea, diaphoresis, tingling, flushing, palpitations, and chest heaviness [<a href="#rid72">72</a>]. Children have been reported with shivering, chills, irritability, screaming, and delirium.</p><p>The mechanism of these reactions has been proposed to involve an exaggerated sensitivity to this compound, which is metabolized after ingestion to glutamate, a major excitatory amino acid neurotransmitter.</p><p>The MSG symptom complex has not been reproduced in controlled challenges, and symptoms were not consistently inducible in 130 patients who were self-identified as sensitive to MSG and challenged in a double-blind manner. Those patients who inconsistently experienced symptoms most often did so only when MSG was ingested in quantities larger than those that would be encountered in a normal diet and without accompanying food [<a href="#rid73">73</a>]. Thus, MSG is regarded as a safe food additive [<a href="#rid74">74,75</a>]. Still, a patient suffering from these symptoms who believes that MSG is the cause can be advised to avoid foods containing added MSG, since this is relatively simple to do. Such patients should particularly avoid liquid foods (such as wonton soup), from which high levels of MSG can be rapidly absorbed.</p><p class="headingAnchor" id="H10181021"><span class="h2">Allergic and asthmatic reactions</span><span class="headingEndMark"> — </span>A small number of case reports have implicated MSG in causing urticaria and angioedema [<a href="#rid74">74,76,77</a>]. As an example, one case described delayed angioedema beginning 16 hours after ingestion of 250 mg MSG, which was reproduced by single-blind, placebo-controlled challenge [<a href="#rid77">77</a>].</p><p>Although MSG has been implicated in provoking asthma [<a href="#rid78">78,79</a>], this association has not been supported in studies characterized by double-blind, placebo-controlled MSG challenges in high-risk asthmatic subjects (aspirin-sensitive or history-positive) [<a href="#rid80">80-82</a>].</p><p>One group of researchers reported a small number of subjects with perennial rhinitis attributed to MSG ingestion and positive responses to double-blind, placebo-controlled oral challenges [<a href="#rid83">83,84</a>]. However, this hypothesis requires further investigation, as MSG could aggravate rhinitis through its vasoactive properties, and the implication that it is a cause of rhinitis has not been established [<a href="#rid74">74</a>].</p><p class="headingAnchor" id="H1752493"><span class="h1">EVALUATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>An evaluation for allergy to a food additive involves a detailed and focused clinical history, a physical examination, possibly skin testing with foods or isolated food additives, and possibly a supervised challenge [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H1752505"><span class="h2">Clinical history</span><span class="headingEndMark"> — </span>The clinician should review each reaction that the patient can clearly recall in detail. (See <a class="local">'Clinical manifestations'</a> above.)</p><p class="headingAnchor" id="H22881236"><span class="h2">Analysis of causative foods</span><span class="headingEndMark"> — </span>Allergic reactions to nutritive foods (such as tree nuts or seafood) are far more prevalent than reactions to food additives, and thus, food allergy must always be considered first in differential diagnosis. Ingredient lists of food items that caused adverse reactions should be carefully compared to determine if there is a nutritive food that is present in each item. If not, then food additives should be considered.</p><p class="bulletIndent1"><span class="glyph">●</span>In the patient with a suggestive history, in whom a suspect additive <strong>can</strong> be identified, a trial of avoidance of the suspected additive would be reasonable. If no further reaction occurs, then this may be sufficiently confirmatory, and no further testing may be needed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the patient with a suggestive history, in whom a suspect additive <strong>cannot</strong> be identified, it is not useful or safe to advise patients to "avoid all additives," particularly if the patient experienced anaphylaxis. (See <a class="local">'Pitfalls of additive-free diets'</a> below.)</p><p></p><p class="bulletIndent1">In patients with history of repeated anaphylaxis in association with eating that cannot be linked to a food or food additive, differential diagnosis should also include other disorders, such as indolent systemic mastocytosis, clonal mast cell disorder, or idiopathic mast cell activation syndrome. In addition, allergy to galactose-alpha-1,3-galactose (alpha-gal), a carbohydrate allergen that can cause delayed anaphylaxis several hours after ingestion of red meat, can evade diagnosis because the reactions occur much later after ingestion than is typical of most food allergies. (See  <a class="medical medical_review" href="/d/html/15715.html" rel="external">"Mast cell disorders: An overview"</a> and  <a class="medical medical_review" href="/d/html/2393.html" rel="external">"Allergy to meats", section on 'Alpha-gal'</a> and  <a class="medical medical_review" href="/d/html/4784.html" rel="external">"Mastocytosis (cutaneous and systemic) in adults: Epidemiology, pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H22881089"><span class="h2">Indications for allergy referral</span><span class="headingEndMark"> — </span>Certain groups of patients suspected to have an allergic or asthmatic reaction to a food additive require further evaluation and should be referred to an allergy expert with knowledge about appropriate testing and challenge procedures:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who have experienced anaphylaxis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with recurrent idiopathic urticaria/angioedema who have refractory or severe symptoms or are dependent upon glucocorticoids to control symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with chronic persistent asthma or life-threatening asthmatic exacerbations.</p><p></p><p>Skin testing and challenge procedures may be needed to make the diagnosis and should be carried out by an allergy expert because these techniques require training and experience to interpret properly. In addition, allergic reactions during these procedures are possible (although uncommon). (See  <a class="medical medical_review" href="/d/html/16707.html" rel="external">"Testing and challenge procedures to evaluate allergic and asthmatic reactions to food additives"</a>.)</p><p>Common goals of allergy evaluation are:</p><p class="bulletIndent1"><span class="glyph">●</span>Proving that a food additive is causing a specific acute reaction, particularly in patients with anaphylaxis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Excluding reactions to food additives and normalizing the diet in people who are avoiding multiple foods because of concerns about possible reactions to food additives.</p><p></p><p class="headingAnchor" id="H7548108"><span class="h2">Pitfalls of additive-free diets</span><span class="headingEndMark"> — </span>Additive-free diets are usually not helpful. These diets are sometimes proposed as an initial means of determining that the patient is sensitive to some additive, without implicating a specific one. As an example, patients may be advised to eat a limited number of specified meats, grains, fruits, and vegetables for three weeks, and if the symptoms improve, then it is concluded that the patient is allergic to some additive. However, this approach has several drawbacks. Patients' symptoms often improve initially, but then gradual reintroduction of commercially prepared foods does not lead to identification of a specific culprit. Sometimes patients remain well for a while despite resuming a normal diet, and then their symptoms eventually return and begin to wax and wane again. In addition, it is difficult to adhere to an additive-free diet for any significant period of time, so most people cannot maintain the exercise for very long.</p><p>For patients who experienced anaphylaxis and who normally eat commercially prepared or processed foods, additive-free diets are difficult to maintain over time, and the patient is likely to resume his/her prior eating habits over time. This approach puts the patient at risk for future recurrences of anaphylaxis. Whenever possible, patients with anaphylaxis should be referred to an allergy specialist so that the chances of identifying the culprit allergen are maximized.</p><p class="headingAnchor" id="H10180860"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Management usually consists of avoidance of commercially prepared foods that are likely to contain the additive in question. The patient should be informed of common foodstuffs that contain the additive, as well as all relevant chemical nomenclature and alternative names for that additive. For patients with asthma, good asthma control is an important aspect of care.</p><p class="headingAnchor" id="H1214102"><span class="h2">Patients with anaphylaxis</span><span class="headingEndMark"> — </span>Any patient who has suffered anaphylaxis should be supplied with an <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> autoinjector, accompanied by verbal and written instructions on how and when to self-administer the drug. Referral to an allergy expert should be arranged when possible. (See  <a class="medical medical_review" href="/d/html/388.html" rel="external">"Prescribing epinephrine for anaphylaxis self-treatment"</a>.)</p><p><a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">Epinephrine</a> autoinjectors contain metabisulfite. However, the injection of the amount of metabisulfite contained in an epinephrine autoinjector did not trigger any symptoms or change in lung function in a small group of sulfite-sensitive asthmatics [<a href="#rid85">85</a>], and there are no case reports to suggest that autoinjectors are unsafe for sulfite-sensitive patients.</p><p>A personalized anaphylaxis action plan is helpful for providing specific instructions to patients about when and how to treat recurrent episodes. Action plan forms are available in English and Spanish from Food Allergy Research and Education (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.foodallergy.org%252Fliving-food-allergies%252Ffood-allergy-essentials%252Ffood-allergy-anaphylaxis-emergency-care-plan%26data%3D04%7C01%7CMichael.Bottari%2540wolterskluwer.com%7C69e354c9a85b41457a2d08d8d9befae3%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C637498761558925481%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C1000%26sdata%3DRDdSv%252BmwjS2IGMJSEEUVZILHzhl4hXgju4PM8DCUzwU%253D%26reserved%3D0&amp;token=t282DwPDIBfsLs5gDG5p%2FcW0IJ1rA3BFgttAxHPnEIr4kjp%2BZKfQqzsTItL7UzEKQOcJe%2BDDLiIYoAbuGc4BL3puRARj12teLH9qoiF0RoHuyrVNoay6MPSBmhTrYPiRafjpeb%2BfC5I%2FewfUaJtgHJMj8XZSE64TuvdAZIoPvqtBbtFODqPpoH3Cwz5HWoHq7%2BcTgMmn5gYlXpRUWvE%2FBRaLoj3%2B54qskJKOAkPY5VpMz1FoYZja%2FCZStv%2FB1QE4zmNS7IqLC6CsMnVMNqkaGnujmBg2uDKzoiGKT78fAb9sFU9h35J16JONhIkDmtHrpgsX1azly45Lsv7JK9NjokZOZ9PMXiytoc1beG6ggIBGfUtQcy8JamSyRSjlKWy9%2FDexDj31Dpx7%2BNAjcEUfgMjzJZqpOGARiGU%2B3gICn9JEx7Jl3B3sk5wPMRP4WlusV0sQ04ExcMg3WJS28jJ7YaDrcwc759XDwzVtRlJLtb4oULk03YDmAr4pNZacfPwo&amp;TOPIC_ID=2405" target="_blank">Food Allergy &amp; Anaphylaxis Emergency Care Plan</a>) and the American Academy of Pediatrics (Allergy and Anaphylaxis Emergency Plan <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.aap.org%252Fen-us%252FDocuments%252FAAP_Allergy_and_Anaphylaxis_Emergency_Plan.pdf%26data%3D04%7C01%7CMichael.Bottari%2540wolterskluwer.com%7C69e354c9a85b41457a2d08d8d9befae3%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C637498761558935434%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C1000%26sdata%3DHh4x2Tg0RXTKuewzO%252BZpSw6TpC5Oma%252BMfoXGb8sTVuk%253D%26reserved%3D0&amp;token=N2qdDpAdBrGIdjO%2Bsh7qdz%2FZEUV2Ug98owpHM%2BdhCSJSyU8Lh6dDyCiKmQlrweKhKKi10F4fvgf9kkn2PDHuNjUTFMTEtYNHWhkd7Z7dru9gxMCXzUSGag%2BVqpOUXnNKv2vHI%2FneEoFCrWiyt8Rjw%2Fd8pZqbwWTQDSU2bzMGF%2BDSlwRx%2BZ0L8od0HKkVWyjSLwYWtjD7Mj4%2B%2FVmvjulhA5k5M7%2FjrDcHsALlnBOQvapr%2FbRnVqUCbvr7rfworeVCJNooIQu3iuIYaTqAKpNoj6eVj3SvPv8VwP3I56JPUZLh4JX1LBQ%2FX7OG1PA2Ywo7MW9rIFsu1GlWodvXqw0qpRgUFX4GCLJV9gtyLcEDRXTEWdbRAWGhkJaCXjyGG8rI8RTMbUnVcBzqDV2KwwfGyTz8IJDicFfHIIP09zxYg%2FHHu85wibw9IR3lQgT7ZAFmcFiJG3Cc7dtG7IKiM7AidLTirXtYzbg4J7Kuh4toalg%3D&amp;TOPIC_ID=2405" target="_blank">English</a>, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fdownloads.aap.org%252FAAP%252FPDF%252FAAEP.Spanish.PDF.rm.1.26.21.pdf%26data%3D04%7C01%7CMichael.Bottari%2540wolterskluwer.com%7C69e354c9a85b41457a2d08d8d9befae3%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C637498761558935434%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C1000%26sdata%3DwgRDRWY1vYMou9UclxHFboaU1iOzsJnUHmMeu7P3i5E%253D%26reserved%3D0&amp;token=s%2FqKNX5dznFbQOE2C4yHLc2iOE47EzLf08uhoPS5wn9B4SREj0U%2FUKar99opEhhvxlsYFMBDHqP0t0Zej6sqR5a7fYK8tPOCsemEFiPMxO1wAbuAtq3uBqTVMD4l%2B517JK7T5rBevgIvpdKEEZWBKTxZv%2FN%2BivZEBMTxla746LphhIGmbS2AVSaYXWuG6Sny3w1G3TwHDL3diN0kSGcf8JYveZ7lm9RGr03DXD2dFQNvnQ1%2FNF%2B%2FDUTF60SQ3QQccg39mxDzJENyCqnadKW09DuvY%2FCr3rOSUcBzsBxWQNvJHP3qDM2jvMYuUgc48bdvupAldFmKocUEO0v1DWsaXV4i6AgNKLDCX85XwvlK%2FgEktJKvnBuzRsxq6bCAT3JomGD%2BcquMXpdvekapPMWTGWMP1aQ8YI3hf3nbJRNwQnxodLHbPkGEe0pK%2BYLQGcoasldDdc%2BmL8NozpeoeuFFPg%3D%3D&amp;TOPIC_ID=2405" target="_blank">Spanish</a>). These plans are appropriate for patients with anaphylaxis from any cause. These materials are discussed separately. (See  <a class="medical medical_review" href="/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment", section on 'Discharge care'</a>.)</p><p class="headingAnchor" id="H23719603"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/15917.html" rel="external">"Patient education: How to use an epinephrine autoinjector (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/365.html" rel="external">"Patient education: Using an epinephrine autoinjector (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H25"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Of the thousands of food additives in use, only a small number have been implicated in allergic or allergic-like reactions. Symptoms include urticaria and/or angioedema, asthmatic reactions, and anaphylaxis. (See <a class="local">'Overview'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clues that a patient may be reacting to a food additive include reactions that occur within minutes to a few hours of eating, a convincing history of similar reactions to several apparently unrelated foods, and reactions to commercially prepared forms of foods that are tolerated when prepared at home. However, allergy to a nutritive food is far more likely than allergy to an additive, so this must be considered first in the differential diagnosis. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Large series of patients with chronic urticaria/angioedema support the conclusion that symptoms are not caused by food additives, although foods and food additives can aggravate the condition in a minority of patients. Patients with recurrent idiopathic urticaria/angioedema who have refractory or severe symptoms or are dependent on glucocorticoids to control symptoms <strong>and</strong> appear to have flares in their symptoms after eating should be referred to an allergy specialist for further evaluation. (See <a class="local">'Urticaria/angioedema'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sulfites can cause potentially serious asthmatic reactions in as many as 5 percent of patients with asthma, whereas individuals without asthma are rarely affected. Sulfite-sensitive patients more often have severe and/or steroid-dependent asthma. Patients with asthma who experience exacerbations after apparent exposure to sulfites should be counseled to avoid sulfite-containing foods  (<a class="graphic graphic_table graphicRef66943" href="/d/graphic/66943.html" rel="external">table 3</a>) and (if possible) referred to an allergy specialist with experience in evaluating for sulfite sensitivity. (See <a class="local">'Sulfites and related compounds'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with aspirin-exacerbated asthma were advised in the past to avoid foods and medications containing tartrazine (FD&amp;C Yellow #5 or E102), because of a notion that tartrazine was cross-reactive with <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>, although there is no convincing evidence to support this conclusion. Tartrazine avoidance is not necessary in patients with asthma. (See <a class="local">'Tartrazine (FD&amp;C Yellow 5)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The preservative <a class="drug drug_general" data-topicid="120131" href="/d/drug information/120131.html" rel="external">sodium benzoate</a> (E211) and the flavorings spearmint, peppermint, and menthol, have each been implicated in causing asthmatic symptoms in one or two case reports supported by challenge procedures. (See <a class="local">'Asthmatic symptoms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anaphylaxis has been reported to annatto (E160b), carmine (E120), saffron, erythritol (ERT), guar gum (E412), <a class="drug drug_general" data-topicid="9834" href="/d/drug information/9834.html" rel="external">psyllium</a>, carrageenan, lupine flour, gelatin, and pectin. These "natural" additives are derived from plants, insects, or animals, and the reactions are believed to be immunoglobulin (IgE)-mediated. Sulfites have been implicated in a very small number of cases of anaphylaxis. (See <a class="local">'Anaphylaxis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An evaluation for allergy to a food additive involves a detailed and focused clinical history, a physical examination, possibly skin testing with foods or isolated food additives, and possibly a supervised challenge. Testing and challenge procedures should be done by an allergy expert, since these techniques require training and experience to interpret correctly and have the potential to cause allergic reactions in very sensitive patients. (See <a class="local">'Evaluation and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Any patient who has experienced anaphylaxis should be supplied with an <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> autoinjector. If the history suggests that a food additive may have been responsible, the patient should be referred to an allergy specialist with experience in performing testing and challenges to food additives. (See <a class="local">'Patients with anaphylaxis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">An alphabetical list of food additives approved for use in the United States is available online at https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htm (Accessed on May 04, 2017).</li><li class="breakAll">A complete list of food additives by E number is available online at www.food.gov.uk/safereating/chemsafe/additivesbranch/enumberlist (Accessed on August 08, 2011).</li><li><a class="nounderline abstract_t">Turner PJ, Kemp AS. Intolerance to food additives - does it exist? J Paediatr Child Health 2012; 48:E10.</a></li><li><a class="nounderline abstract_t">Young E, Patel S, Stoneham M, et al. The prevalence of reaction to food additives in a survey population. J R Coll Physicians Lond 1987; 21:241.</a></li><li><a class="nounderline abstract_t">Sampson HA, Aceves S, Bock SA, et al. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol 2014; 134:1016.</a></li><li><a class="nounderline abstract_t">Simon RA. Adverse reactions to food and drug additives. Immunol Allergy Clin North Am 1996; 16:137.</a></li><li><a class="nounderline abstract_t">Wilson BG, Bahna SL. Adverse reactions to food additives. Ann Allergy Asthma Immunol 2005; 95:499.</a></li><li><a class="nounderline abstract_t">Ortolani C, Pastorello E, Fontana A, et al. Chemicals and drugs as triggers of food-associated disorder. Ann Allergy 1988; 60:358.</a></li><li><a class="nounderline abstract_t">Genton C, Frei PC, Pécoud A. Value of oral provocation tests to aspirin and food additives in the routine investigation of asthma and chronic urticaria. J Allergy Clin Immunol 1985; 76:40.</a></li><li><a class="nounderline abstract_t">Asero R. Multiple intolerance to food additives. J Allergy Clin Immunol 2002; 110:531.</a></li><li><a class="nounderline abstract_t">Worm M, Ehlers I, Sterry W, Zuberbier T. Clinical relevance of food additives in adult patients with atopic dermatitis. Clin Exp Allergy 2000; 30:407.</a></li><li><a class="nounderline abstract_t">Bock SA, Sampson HA, Atkins FM, et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol 1988; 82:986.</a></li><li><a class="nounderline abstract_t">Sampson HA. Food allergy. Part 2: diagnosis and management. J Allergy Clin Immunol 1999; 103:981.</a></li><li><a class="nounderline abstract_t">Rajan JP, Simon RA, Bosso JV. Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria. J Allergy Clin Immunol Pract 2014; 2:168.</a></li><li><a class="nounderline abstract_t">Goodman DL, McDonnell JT, Nelson HS, et al. Chronic urticaria exacerbated by the antioxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). J Allergy Clin Immunol 1990; 86:570.</a></li><li><a class="nounderline abstract_t">Aspinall RL, Saunders RN, Pautsch WF, Nutting EF. The biological properties of aspartame. V. Effects on a variety of physiological parameters related to inflammation and metabolism. J Environ Pathol Toxicol 1980; 3:387.</a></li><li><a class="nounderline abstract_t">Kulczycki A Jr. Aspartame-induced urticaria. Ann Intern Med 1986; 104:207.</a></li><li><a class="nounderline abstract_t">Kulczycki A Jr. Aspartame-induced hives. J Allergy Clin Immunol 1995; 95:639.</a></li><li><a class="nounderline abstract_t">Garriga MM, Berkebile C, Metcalfe DD. A combined single-blind, double-blind, placebo-controlled study to determine the reproducibility of hypersensitivity reactions to aspartame. J Allergy Clin Immunol 1991; 87:821.</a></li><li><a class="nounderline abstract_t">Geha R, Buckley CE, Greenberger P, et al. Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study. J Allergy Clin Immunol 1993; 92:513.</a></li><li><a class="nounderline abstract_t">Pérez-Calderón R, Gonzalo-Garijo MA, Lamilla-Yerga A, et al. Recurrent angioedema due to lysozyme allergy. J Investig Allergol Clin Immunol 2007; 17:264.</a></li><li><a class="nounderline abstract_t">Stevenson DD, Simon RA. Sensitivity to ingested metabisulfites in asthmatic subjects. J Allergy Clin Immunol 1981; 68:26.</a></li><li><a class="nounderline abstract_t">Bush RK, Taylor SL, Holden K, et al. Prevalence of sensitivity to sulfiting agents in asthmatic patients. Am J Med 1986; 81:816.</a></li><li><a class="nounderline abstract_t">Simon RA. Update on sulfite sensitivity. Allergy 1998; 53:78.</a></li><li><a class="nounderline abstract_t">Baker GJ, Collett P, Allen DH. Bronchospasm induced by metabisulphite-containing foods and drugs. Med J Aust 1981; 2:614.</a></li><li><a class="nounderline abstract_t">Simon RA, Green L, Stevenson DD. The incidence of metabisulfite sensitivity in an asthmatic population. J Allergy Clin Immunol 1982; 69:118.</a></li><li><a class="nounderline abstract_t">Buckley R, Saltzman HA, Sieker HO. The prevalence and degree of sensitivity to ingested sulfites. J Allergy Clin Immunol 1985; 77:144.</a></li><li><a class="nounderline abstract_t">Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68:975.</a></li><li><a class="nounderline abstract_t">Settipane GA, Pudupakkam RK. Aspirin intolerance. III. Subtypes, familial occurence, and cross-reactivity with tartarazine. J Allergy Clin Immunol 1975; 56:215.</a></li><li><a class="nounderline abstract_t">Spector SL, Wangaard CH, Farr RS. Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol 1979; 64:500.</a></li><li><a class="nounderline abstract_t">Stenius BS, Lemola M. Hypersensitivity to acetylsalicylic acid (ASA) and tartrazine in patients with asthma. Clin Allergy 1976; 6:119.</a></li><li><a class="nounderline abstract_t">Weber RW, Hoffman M, Raine DA Jr, Nelson HS. Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol 1979; 64:32.</a></li><li><a class="nounderline abstract_t">Vedanthan PK, Menon MM, Bell TD, Bergin D. Aspirin and tartrazine oral challenge: incidence of adverse response in chronic childhood asthma. J Allergy Clin Immunol 1977; 60:8.</a></li><li><a class="nounderline abstract_t">Stevenson DD, Simon RA, Lumry WR, Mathison DA. Adverse reactions to tartrazine. J Allergy Clin Immunol 1986; 78:182.</a></li><li><a class="nounderline abstract_t">Ardern KD, Ram FS. Tartrazine exclusion for allergic asthma. Cochrane Database Syst Rev 2001; :CD000460.</a></li><li><a class="nounderline abstract_t">Pestana S, Moreira M, Olej B. Safety of ingestion of yellow tartrazine by double-blind placebo controlled challenge in 26 atopic adults. Allergol Immunopathol (Madr) 2010; 38:142.</a></li><li><a class="nounderline abstract_t">Tarlo SM, Broder I. Tartrazine and benzoate challenge and dietary avoidance in chronic asthma. Clin Allergy 1982; 12:303.</a></li><li><a class="nounderline abstract_t">Spurlock BW, Dailey TM. Shortness of (fresh) breath--toothpaste-induced bronchospasm. N Engl J Med 1990; 323:1845.</a></li><li><a class="nounderline abstract_t">Subiza J, Subiza JL, Valdivieso R, et al. Toothpaste flavor-induced asthma. J Allergy Clin Immunol 1992; 90:1004.</a></li><li><a class="nounderline abstract_t">Paiva M, Piedade S, Gaspar A. Toothpaste-induced anaphylaxis caused by mint (Mentha) allergy. Allergy 2010; 65:1201.</a></li><li><a class="nounderline abstract_t">Prenner BM, Stevens JJ. Anaphylaxis after ingestion of sodium bisulfite. Ann Allergy 1976; 37:180.</a></li><li><a class="nounderline abstract_t">Yunginger JW, Jones RT, Kita H, et al. Allergic reactions after ingestion of erythritol-containing foods and beverages. J Allergy Clin Immunol 2001; 108:650.</a></li><li><a class="nounderline abstract_t">Nish WA, Whisman BA, Goetz DW, Ramirez DA. Anaphylaxis to annatto dye: a case report. Ann Allergy 1991; 66:129.</a></li><li><a class="nounderline abstract_t">Beaudouin E, Kanny G, Lambert H, et al. Food anaphylaxis following ingestion of carmine. Ann Allergy Asthma Immunol 1995; 74:427.</a></li><li><a class="nounderline abstract_t">Ebo DG, Ingelbrecht S, Bridts CH, Stevens WJ. Allergy for cheese: evidence for an IgE-mediated reaction from the natural dye annatto. Allergy 2009; 64:1558.</a></li><li><a class="nounderline abstract_t">Greenhawt MJ, Baldwin JL. Carmine dye and cochineal extract: hidden allergens no more. Ann Allergy Asthma Immunol 2009; 103:73.</a></li><li><a class="nounderline abstract_t">DiCello MC, Myc A, Baker JR Jr, Baldwin JL. Anaphylaxis after ingestion of carmine colored foods: two case reports and a review of the literature. Allergy Asthma Proc 1999; 20:377.</a></li><li><a class="nounderline abstract_t">Greenhawt M, McMorris M, Baldwin J. Carmine hypersensitivity masquerading as azithromycin hypersensitivity. Allergy Asthma Proc 2009; 30:95.</a></li><li><a class="nounderline abstract_t">Roesch A, Haegele T, Vogt T, et al. Severe contact urticaria to guar gum included as gelling agent in a local anaesthetic. Contact Dermatitis 2005; 52:307.</a></li><li><a class="nounderline abstract_t">Papanikolaou I, Stenger R, Bessot JC, et al. Anaphylactic shock to guar gum (food additive E412) contained in a meal substitute. Allergy 2007; 62:822.</a></li><li><a class="nounderline abstract_t">Lemière C, Cartier A, Malo JL, Lehrer SB. Persistent specific bronchial reactivity to occupational agents in workers with normal nonspecific bronchial reactivity. Am J Respir Crit Care Med 2000; 162:976.</a></li><li><a class="nounderline abstract_t">Malo JL, Cartier A, L'Archevêque J, et al. Prevalence of occupational asthma and immunologic sensitization to guar gum among employees at a carpet-manufacturing plant. J Allergy Clin Immunol 1990; 86:562.</a></li><li><a class="nounderline abstract_t">James JM, Cooke SK, Barnett A, Sampson HA. Anaphylactic reactions to a psyllium-containing cereal. J Allergy Clin Immunol 1991; 88:402.</a></li><li><a class="nounderline abstract_t">Malo JL, Cartier A, L'Archevêque J, et al. Prevalence of occupational asthma and immunologic sensitization to psyllium among health personnel in chronic care hospitals. Am Rev Respir Dis 1990; 142:1359.</a></li><li><a class="nounderline abstract_t">Schwartz HJ, Arnold JL, Strohl KP. Occupational allergic rhinitis reaction to psyllium. J Occup Med 1989; 31:624.</a></li><li><a class="nounderline abstract_t">Cartier A, Malo JL, Dolovich J. Occupational asthma in nurses handling psyllium. Clin Allergy 1987; 17:1.</a></li><li><a class="nounderline abstract_t">Yang WH, Purchase EC, Rivington RN. Positive skin tests and Prausnitz-Küstner reactions in metabisulfite-sensitive subjects. J Allergy Clin Immunol 1986; 78:443.</a></li><li><a class="nounderline abstract_t">Cifuentes L, Ring J, Brockow K. Clonal mast cell activation syndrome with anaphylaxis to sulfites. Int Arch Allergy Immunol 2013; 162:94.</a></li><li><a class="nounderline abstract_t">Meggs WJ, Atkins FM, Wright R, et al. Failure of sulfites to produce clinical responses in patients with systemic mastocytosis or recurrent anaphylaxis: results of a single-blind study. J Allergy Clin Immunol 1985; 76:840.</a></li><li><a class="nounderline abstract_t">Stricker WE, Anorve-Lopez E, Reed CE. Food skin testing in patients with idiopathic anaphylaxis. J Allergy Clin Immunol 1986; 77:516.</a></li><li><a class="nounderline abstract_t">Sonin L, Patterson R. Metabisulfite challenge in patients with idiopathic anaphylaxis. J Allergy Clin Immunol 1985; 75:67.</a></li><li><a class="nounderline abstract_t">Tarlo SM, Dolovich J, Listgarten C. Anaphylaxis to carrageenan: a pseudo-latex allergy. J Allergy Clin Immunol 1995; 95:933.</a></li><li><a class="nounderline abstract_t">Peeters KA, Nordlee JA, Penninks AH, et al. Lupine allergy: not simply cross-reactivity with peanut or soy. J Allergy Clin Immunol 2007; 120:647.</a></li><li><a class="nounderline abstract_t">De las Marinas D, Cojocariu Z, Escudero R, et al. Anaphylaxis induced by lupine as a hidden allergen. J Investig Allergol Clin Immunol 2007; 17:283.</a></li><li><a class="nounderline abstract_t">Ferdman RM, Ong PY, Church JA. Pectin anaphylaxis and possible association with cashew allergy. Ann Allergy Asthma Immunol 2006; 97:759.</a></li><li><a class="nounderline abstract_t">Wang J, Sicherer SH. Anaphylaxis following ingestion of candy fruit chews. Ann Allergy Asthma Immunol 2005; 94:530.</a></li><li><a class="nounderline abstract_t">Scurlock AM, Althage KA, Christie L, et al. Anaphylaxis after ingestion of gummy bears. J Allergy Clin Immunol 2002; 110:936.</a></li><li><a class="nounderline abstract_t">Sandhu MS, Hopp RJ. Type I hypersensitivity reaction to ingestion of mycoprotein (quorn) in a patient with mold allergy. Pediatric Asthma Allergy and Immunology 2009; 22:5.</a></li><li><a class="nounderline abstract_t">Tee RD, Gordon DJ, Welch JA, Newman Taylor AJ. Investigation of possible adverse allergic reactions to mycoprotein ('Quorn'). Clin Exp Allergy 1993; 23:257.</a></li><li><a class="nounderline abstract_t">Hoff M, Trüeb RM, Ballmer-Weber BK, et al. Immediate-type hypersensitivity reaction to ingestion of mycoprotein (Quorn) in a patient allergic to molds caused by acidic ribosomal protein P2. J Allergy Clin Immunol 2003; 111:1106.</a></li><li><a class="nounderline abstract_t">Moneret-Vautrin DA, Morisset M, Lemerdy P, et al. Food allergy and IgE sensitization caused by spices: CICBAA data (based on 589 cases of food allergy). Allerg Immunol (Paris) 2002; 34:135.</a></li><li><a class="nounderline abstract_t">Yang WH, Drouin MA, Herbert M, et al. The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study. J Allergy Clin Immunol 1997; 99:757.</a></li><li><a class="nounderline abstract_t">Geha RS, Beiser A, Ren C, et al. Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study. J Nutr 2000; 130:1058S.</a></li><li><a class="nounderline abstract_t">Williams AN, Woessner KM. Monosodium glutamate 'allergy': menace or myth? Clin Exp Allergy 2009; 39:640.</a></li><li><a class="nounderline abstract_t">Walker R, Lupien JR. The safety evaluation of monosodium glutamate. J Nutr 2000; 130:1049S.</a></li><li><a class="nounderline abstract_t">RANDOLPH TG, ROLLINS JP. Beet sensitivity: allergic reactions from the ingestion of beet sugar (sucrose) and monosodium glutamate of beet origin. J Lab Clin Med 1950; 36:407.</a></li><li><a class="nounderline abstract_t">Squire EN Jr. Angio-oedema and monosodium glutamate. Lancet 1987; 1:988.</a></li><li><a class="nounderline abstract_t">Allen DH, Baker GJ. Chinese-restaurant asthma. N Engl J Med 1981; 305:1154.</a></li><li><a class="nounderline abstract_t">Allen DH, Baker GJ. Asthma and MSG. Med J Aust 1981; 2:576.</a></li><li><a class="nounderline abstract_t">Woessner KM, Simon RA, Stevenson DD. Monosodium glutamate sensitivity in asthma. J Allergy Clin Immunol 1999; 104:305.</a></li><li><a class="nounderline abstract_t">Woods RK, Weiner JM, Thien F, et al. The effects of monosodium glutamate in adults with asthma who perceive themselves to be monosodium glutamate-intolerant. J Allergy Clin Immunol 1998; 101:762.</a></li><li><a class="nounderline abstract_t">Zhou Y, Yang M, Dong BR. Monosodium glutamate avoidance for chronic asthma in adults and children. Cochrane Database Syst Rev 2012; :CD004357.</a></li><li><a class="nounderline abstract_t">Asero R. Food additives intolerance: a possible cause of perennial rhinitis. J Allergy Clin Immunol 2002; 110:937.</a></li><li><a class="nounderline abstract_t">Asero R, Bottazzi G. Chronic rhinitis with nasal polyposis associated with sodium glutamate intolerance. Int Arch Allergy Immunol 2007; 144:159.</a></li><li class="breakAll">Simon R, unpublished data. (These challenges were performed subcutaneously because that was the recommended route of epinephrine injection at the time).</li></ol></div><div id="topicVersionRevision">Topic 2405 Version 15.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htm" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : An alphabetical list of food additives approved for use in the United States is available online at https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htm (Accessed on May 04, 2017).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="www.food.gov.uk/safereating/chemsafe/additivesbranch/enumberlist" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A complete list of food additives by E number is available online at www.food.gov.uk/safereating/chemsafe/additivesbranch/enumberlist (Accessed on August 08, 2011).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22320279" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Intolerance to food additives - does it exist?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3681784" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The prevalence of reaction to food additives in a survey population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25174862" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Food allergy: a practice parameter update-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Adverse reactions to food and drug additives</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16400887" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Adverse reactions to food additives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3358540" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Chemicals and drugs as triggers of food-associated disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2861222" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Value of oral provocation tests to aspirin and food additives in the routine investigation of asthma and chronic urticaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12209108" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Multiple intolerance to food additives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10691900" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Clinical relevance of food additives in adult patients with atopic dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3060514" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10359874" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Food allergy. Part 2: diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24607044" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2229816" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Chronic urticaria exacerbated by the antioxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6108346" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The biological properties of aspartame. V. Effects on a variety of physiological parameters related to inflammation and metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3946947" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Aspartame-induced urticaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7852678" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Aspartame-induced hives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2013676" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A combined single-blind, double-blind, placebo-controlled study to determine the reproducibility of hypersensitivity reactions to aspartame.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8409113" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694700" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Recurrent angioedema due to lysozyme allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7240597" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Sensitivity to ingested metabisulfites in asthmatic subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3535492" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prevalence of sensitivity to sulfiting agents in asthmatic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9826006" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Update on sulfite sensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7334982" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Bronchospasm induced by metabisulphite-containing foods and drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The incidence of metabisulfite sensitivity in an asthmatic population</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The prevalence and degree of sensitivity to ingested sulfites</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5646829" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1151014" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Aspirin intolerance. III. Subtypes, familial occurence, and cross-reactivity with tartarazine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/512268" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Aspirin and concomitant idiosyncrasies in adult asthmatic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1277437" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Hypersensitivity to acetylsalicylic acid (ASA) and tartrazine in patients with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/447949" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/326850" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Aspirin and tartrazine oral challenge: incidence of adverse response in chronic childhood asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3722646" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Adverse reactions to tartrazine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11687081" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Tartrazine exclusion for allergic asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20106580" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Safety of ingestion of yellow tartrazine by double-blind placebo controlled challenge in 26 atopic adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7105394" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Tartrazine and benzoate challenge and dietary avoidance in chronic asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2247130" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Shortness of (fresh) breath--toothpaste-induced bronchospasm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1460190" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Toothpaste flavor-induced asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20148803" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Toothpaste-induced anaphylaxis caused by mint (Mentha) allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/962196" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Anaphylaxis after ingestion of sodium bisulfite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11590396" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Allergic reactions after ingestion of erythritol-containing foods and beverages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1994783" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Anaphylaxis to annatto dye: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7538438" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Food anaphylaxis following ingestion of carmine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19772519" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Allergy for cheese: evidence for an IgE-mediated reaction from the natural dye annatto.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19663130" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Carmine dye and cochineal extract: hidden allergens no more.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10624494" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Anaphylaxis after ingestion of carmine colored foods: two case reports and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19331724" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Carmine hypersensitivity masquerading as azithromycin hypersensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15932579" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Severe contact urticaria to guar gum included as gelling agent in a local anaesthetic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17573733" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Anaphylactic shock to guar gum (food additive E412) contained in a meal substitute.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10988116" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Persistent specific bronchial reactivity to occupational agents in workers with normal nonspecific bronchial reactivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2229815" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Prevalence of occupational asthma and immunologic sensitization to guar gum among employees at a carpet-manufacturing plant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1890270" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Anaphylactic reactions to a psyllium-containing cereal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2252254" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Prevalence of occupational asthma and immunologic sensitization to psyllium among health personnel in chronic care hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2769459" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Occupational allergic rhinitis reaction to psyllium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3829366" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Occupational asthma in nurses handling psyllium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3760403" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Positive skin tests and Prausnitz-Küstner reactions in metabisulfite-sensitive subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23816954" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clonal mast cell activation syndrome with anaphylaxis to sulfites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3905921" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Failure of sulfites to produce clinical responses in patients with systemic mastocytosis or recurrent anaphylaxis: results of a single-blind study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3950255" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Food skin testing in patients with idiopathic anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3968330" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Metabisulfite challenge in patients with idiopathic anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7751512" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Anaphylaxis to carrageenan: a pseudo-latex allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17637469" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Lupine allergy: not simply cross-reactivity with peanut or soy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694709" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Anaphylaxis induced by lupine as a hidden allergen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17201234" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Pectin anaphylaxis and possible association with cashew allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15945554" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Anaphylaxis following ingestion of candy fruit chews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12464963" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Anaphylaxis after ingestion of gummy bears.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Type I hypersensitivity reaction to ingestion of mycoprotein (quorn) in a patient with mold allergy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8319120" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Investigation of possible adverse allergic reactions to mycoprotein ('Quorn').</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12743577" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Immediate-type hypersensitivity reaction to ingestion of mycoprotein (Quorn) in a patient allergic to molds caused by acidic ribosomal protein P2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12078423" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Food allergy and IgE sensitization caused by spices: CICBAA data (based on 589 cases of food allergy).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9215242" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10736382" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19389112" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Monosodium glutamate 'allergy': menace or myth?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10736380" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The safety evaluation of monosodium glutamate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14774619" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Beet sensitivity: allergic reactions from the ingestion of beet sugar (sucrose) and monosodium glutamate of beet origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2882387" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Angio-oedema and monosodium glutamate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7290124" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Chinese-restaurant asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7334969" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Asthma and MSG.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10452749" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Monosodium glutamate sensitivity in asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9648703" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : The effects of monosodium glutamate in adults with asthma who perceive themselves to be monosodium glutamate-intolerant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22696342" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Monosodium glutamate avoidance for chronic asthma in adults and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12464964" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Food additives intolerance: a possible cause of perennial rhinitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17536215" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Chronic rhinitis with nasal polyposis associated with sodium glutamate intolerance.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
